Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Volume 16, Issue 3 (May 2014) 16, 359–363; doi: 10.4103/1008-682X.126400

Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer

Costantine Albany, Noah M Hahn

Indiana University Health, Melvin and Bern Simon Cancer Center, Indianapolis, IN, USA.

Correspondence: Dr. NM Hahn (nhahn@iu.edu)

Received: 19 December 2013; Revised: 13 January 2014; Accepted: 14 January 2014


Defects within apoptotic pathways have been implicated in prostate cancer (PCa) tumorigenesis, metastatic progression and treatment resistance. A hallmark of cancers is the ability to derail apoptosis by inhibiting the apoptotic signal, reducing the expression of apoptotic proteins and/or amplifying survival signals through increased production of antiapoptotic molecule. This review describes associations between heat shock proteins (HSPs) and the human androgen receptor (AR), the role of HSPs and other stress-induced proteins in PCa development and emerging strategies in targeting these protective proteins to treat PCa.

Keywords: apatorsen; apoptosis; bcl‑2 homologous antagonist‑killer protein; clusterin; custirsen; ganetespib; heat‑shock proteins; prostatic neoplasms

Full Text | PDF | 中文摘要 |

Browse:  1664
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved